Notice of Intent to Sole Source to Illumina, Inc

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc for purchase of sequencing reagents. The chemistry in illumina sequencing reagents are designed specifically to be used with illumina sequencing systems which includes different steps starting from DNA library preparations to the actual sequencing process of bacterial genomes.These are the only products that is compatible for and required to run Miseq and/or Hiseq sequencers from Illumina. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at [email protected] by COB 10 June 2020